# Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD

> **NCT00759018** · — · NO_LONGER_AVAILABLE · sponsor: **Mesoblast, Inc.**

## Conditions studied

- Graft vs Host Disease
- Graft-Versus-Host Disease

## Interventions

- **BIOLOGICAL:** remestemcel-L

## Key facts

- **NCT ID:** NCT00759018
- **Lead sponsor:** Mesoblast, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-03-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00759018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00759018, "Prochymal Expanded Access Treatment for Pediatric Patients Who Have Failed Steroids for Acute GVHD". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT00759018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*